Lynn Wenger

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Search Results

Reduced emergency department visits and hospitalisation with use of an unsanctioned safe consumption site for injection drug use in the United States

Buprenorphine implementation at syringe service programs following waiver of the Ryan Haight Act in the United States

When adaptation creates an unsanctioned environment: Understanding implementation and effectiveness of the first supervised consumption site in the United States

Understanding the impact of COVID-19 on naloxone distribution from syringe service programs in the United States

Waiver of the Ryan Haight Act and implementation of buprenorphine treatment at syringe service programs

Best practices for community-based overdose education and naloxone distribution programs: Results from using the Delphi approach

Predictors of protein intake among people who inject drugs in Los Angeles and San Francisco, California

Health risk associated with residential relocation among people who inject drugs in Los Angeles and San Francisco, CA: A cross sectional study

Establishment and enforcement of operational rules at an unsanctioned safe drug consumption site in the United States, 2014-2020

Effect of an unsanctioned safe consumption site in the United States on syringe sharing, rushed injections, and isolated injection drug use: A longitudinal cohort analysis

Improved syringe disposal practices associated with unsanctioned safe consumption site use: A cohort study of people who inject drugs in the United States

Factors associated with injury and blood-borne infection risk when providing assisted injection among people who inject drugs

Transition from injecting opioids to smoking fentanyl in San Francisco, California

Prevalence and predictors of recent temporary psychiatric hold among a cohort of people who inject drugs in Los Angeles and San Francisco, California

Bridging institutional logics: Implementing naloxone distribution for people exiting jail in three California counties

Ingenuity and resiliency of syringe service programs on the front lines of the opioid overdose and COVID-19 crises

The naloxone delivery cascade: Identifying disparities in access to naloxone among people who inject drugs in Los Angeles and San Francisco, CA

Factors associated with methamphetamine withdrawal symptoms among people who inject drugs

Assisted injection provider practices and motivations in Los Angeles and San Francisco California 2016-18

Understanding the influence of external and internal characteristics on the penetration of naloxone delivery from syringe service programs in the United States